Fund Holdings — Propel Bio Management, LLC

Total Portfolio Value
$99.89M
Total Bought
$23.14M
Total Sold
$6.85M
Net Transaction
+$16.29M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
MILESTONE PHARMACEUTICALS(MIST)1,791,5575,124,890+3,333,3333,47610,25010.26%+6,774
CELLDEX THERAPEUTICS INC(CLDX)0155,000+155,00004,0104.01%+4,010
APPLIED THERAPEUTICS INC11,285,42011,285,42003,5116,8276.83%+3,316
COMPASS PATHWAYS PLC(CMPS)0510,000+510,00002,9222.93%+2,922
NEKTAR THERAPEUTICS(NKTR)049,000+49,00002,7882.79%+2,788
JASPER THERAPEUTICS INC(JSPR)01,028,806+1,028,80602,4492.45%+2,449
VIRIDIAN THERAPEUTICS INC(VRDN)090,000+90,00001,9421.94%+1,942
DELCATH SYSTEMS INC(DCTH)226,052438,509+212,4573,0744,7144.72%+1,640
ATHIRA PHARMA INC(LONA)0149,279+149,27906180.62%+618
TSCAN THERAPEUTICS INC(TCRX)2,087,1391,932,304-154,8353,0263,5173.52%+490
ZEVRA THERAPEUTICS INC(ZVRA)231,874231,87402,0432,2052.21%+162
CHINOOK THERAPEUTICS79,3570-79,35730—-2
WTS - Achieve Life Sci3,699,9990-3,699,999140—-14
ABEONA THERAPEUTICS INC(ABEO)974,022974,02205,5325,1435.15%-390
EIGER BIOPHARMACEUTICALS146,3810-146,3814230—-423
ATHIRA PHARMA INC1,492,7920-1,492,7924510—-451
MAAT PHARMA SACA94,1810-94,1814520—-452
CAPRICOR THERAPEUTICS INC(CAPR)70,0000-70,0006950—-695
AKERO THERAPEUTICS INC228,884228,884012,21310,86710.88%-1,346
PLAINS GP HOLDINGS LP-CL(PAGP)1,272,3601,272,360024,72223,20823.23%-1,514
ACHIEVE LIFE SCIENCES INC6,153,0913,786,425-2,366,66613,90611,92711.94%-1,979
PHATHOM PHARMACEUTICALS I(PHAT)922,927552,927-370,0008,8516,5086.51%-2,343
Page 1 of 1
Propel Bio Management, LLC — 13F Holdings — Q3 2025 | TickerTrail